Analysis of 117 Cases of Adverse Drug Reaction/Event Induced by Traditional Chinese Medicine

Abstract

Abstract: Objective To understand the characteristics of the adverse drug reaction/event(ADR/ADE) of Eraditional chinese Medicine to promote clinical rational drug use. Methods 117 ADR/ADE reports of Traditional Chinese Medicine were analyzed retrospectively. Results 59 cases of Traditional Chinese Medicine injections accounted for 49.6%; 31 cases of Quyu agent involved in 24.8 percent accounted for 15 Varieties of drugs. Conclusion Dialectical view of adverse reactions and the monitoring of adverse reactions to Traditional Chinese Medicine, should be strengthened to reduce the ADR/ADE incidence.

Key words: Traditional Chinese Medicine, adverse drug reaction/event(ADR/ADE), reasonable medication, medication monitoring

CLC Number:

R286

ZHANG Yan, XIE Yu-tao, CHEN Jin-xin, LI Lin. Analysis of 117 Cases of Adverse Drug Reaction/Event Induced by Traditional Chinese Medicine[J]. Chinese Journal of Pharmacovigilance, 2010, 7(4): 237-239.

Add to citation manager EndNote|Ris|BibTeX

URL: https://zgywjj.magtechjournal.com/EN/

https://zgywjj.magtechjournal.com/EN/Y2010/V7/I4/237

[1]	CHEN Siying, DING Xueli, LIU Shujia, ZHANG Xiaomeng, ZHANG Bing, LIN Zhijian. Modeling for Prediction of Cardiotoxicity of Chinese Herbal Medicines [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 869-875.
[2]	LIU Lianlian, YU Huiyong, WANG Mingzhe, GUO Shanshan, LI Lei, GAO Yue, WEI Shixiang, KE Yinze, WANG Chengxiang. TCM Medications for Pulmonary Nodules Based on Traditional Chinese Medicine Inheritance Assistance System [J]. Chinese Journal of Pharmacovigilance, 2025, 22(5): 513-516.
[3]	LI Shuran, XIE Rui, ZHAO Ronghua, BAO Lei, GENG Zihan, SUN Qiyue, CUI Xiaolan, GUO Shanshan, SUN Jing. Research Progress in the Pathogenesis and Medications of Trigeminal Neuralgia [J]. Chinese Journal of Pharmacovigilance, 2025, 22(5): 596-600.
[4]	GUO Dongqi, WANG Hao, BAI Xin, BAI Jianqi, SU Hongmei, ZHANG Jingru, GUO Xiaofei, ZHAO Xiaoqi, WANG Min, WANG Yuan, ZHANG Ping. Identification of Druggable Targets for Intervertebral Disc Degeneration Based on Multi-Omics Data-Driven Mendelian Randomization and Prediction of Traditional Chinese Medicine Interventions [J]. Chinese Journal of Pharmacovigilance, 2025, 22(3): 241-248.
[5]	BAI Xin, WANG Min, WANG Yuan, BAI Jianqi, SU Shuang, LIU Guanghui, GUO Xiaofei, KANG Jiaqi, GUO Dongqi, ZHANG Yimeng, WANG Hao, ZHAO Xiaoqi, ZHANG Ping. Traditional Chinese Medicine Used in the Treatment of Gout Complicated with Osteoarthritis [J]. Chinese Journal of Pharmacovigilance, 2025, 22(3): 258-262.
[6]	JIA Zhichao, HU Siyuan, LI Ruiben, XU Yaqian. Safety of Children’s Traditional Chinese Medicine Decoction Pieces in Clinical Application and Children’s Drug Development [J]. Chinese Journal of Pharmacovigilance, 2025, 22(3): 324-328.
[7]	LIANG Xiao, LI Li, XU Xiaolong, BAI Yinglu, YANG Yumei, ZHU Yong, LIU Qingquan. Advancements in Treatment of Brucellosis with Traditional Chinese Medicine [J]. Chinese Journal of Pharmacovigilance, 2025, 22(2): 231-234.
[8]	SHAO Bo, GUO Xiaoxin. Review of pharmacovigilance of traditional Chinese medicine [J]. Chinese Journal of Pharmacovigilance, 2024, 21(7): 741-745.
[9]	LIU Yang, FAN Zheng, WANG Honglei, YANG Ying, GUO Qi, CHANG Xinyu, HAN Lijuan, LI Wenzhe, WU Jiankun. Therapeutic effect of Jingzhui Kangfu pills against osteoarthritis induced by proteoglycan in mice [J]. Chinese Journal of Pharmacovigilance, 2024, 21(6): 651-654.
[10]	LI Yao, CHEN Yuxin, GAO Haiyun, LI Hui, LIU Tianrui, YUAN Yuan. Analysis of prescription rules for Omphalia lapidescens based on the Dictionary of Chinese Traditional Medicine Prescriptions [J]. Chinese Journal of Pharmacovigilance, 2024, 21(5): 553-558.
[11]	LIU Qi, ZHANG Yufeng, LUO Hao, LI Xin. Analysis of the rationality and safety of clinical application of anrotinib in a hospital [J]. Chinese Journal of Pharmacovigilance, 2024, 21(3): 329-334.
[12]	LI Jiaxin, LIU Huimin, QIAN Wenxiu, MA Ning, SONG Lili, LI Yubo. Nephrotoxic effects and usage of traditional Chinese medicines based on the Traditional Chinese Medicine Systems Toxicology Database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 173-180.
[13]	ZHANG Jian, FANG Huihua. Applicability of evaluation standards for use of traditional Chinese medicine injections for promoting blood circulation and removing blood stasis [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 185-189.
[14]	LIU Sujie, YAN Jiahe, RUAN Jiaxin, WANG Chen, WANG Xiaofan, LIU Shumin, BAI Xue. Research Progress in Regulation of Wnt/β-Catenin Signaling Pathway by TCM in the Treatment of Ischemic Stroke [J]. Chinese Journal of Pharmacovigilance, 2024, 21(12): 1388-1392.
[15]	ZHENG Enqi, BAI Xue. Analysis and Research on the Mechanism of Cerebral Ischemia in China [J]. Chinese Journal of Pharmacovigilance, 2024, 21(12): 1398-1404.

Analysis of 117 Cases of Adverse Drug Reaction/Event Induced by Traditional Chinese Medicine

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics